» Articles » PMID: 31380154

Studying the Impact of Young Age on Prognosis and Treatment in Laryngeal Squamous Cell Carcinomas Using the SEER Database

Overview
Journal PeerJ
Date 2019 Aug 6
PMID 31380154
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Laryngeal squamous cell carcinoma (LSCC) in young patients was reported to be more aggressive and associated with poorer survival than in older patients. However, very few studies contained sufficient cases to permit meaningful statistical analysis. It is still unknown whether less aggressive method like radical radiotherapy (RT) is comparable to total laryngectomy (TL) in survival rate among young patients.

Methods: This study extracted patient data from the surveillance, epidemiology, and end results database from 2004 to 2015. The findings for 304 patients (1.2%) below the age of 40 were compared with those for 24,827 patients (98.8%) aged 40 or older.

Results: The younger cohorts contained a higher proportion of female patients (33.6% vs. 19.1%, respectively), had more cases of glottic involvement (64.5% vs. 53.1%), and were less likely to have distant metastasis (0.7% vs.3.2%). A total of 5-year overall survival and cancer-specific survival rates (CSS) in the younger patients were 86.3% and 88.8%, respectively, significantly better than for older patients (53.8% and 67.6%). Significant differences were still observed when stratified for tumor stage (stage I-IV). The negative independent prognostic factors in younger patients were advanced tumor stage, degree of nodal involvement, and status of distant metastasis. Treatment with surgery and/or RT all produced excellent outcomes in stage I-IV diseases, and radical RT resulted in survival rates equal to those for TL in locally advanced LSCC among young patients (5-year CSS: 90% vs. 91.5%, = 0.99).

Conclusion: LSCC is less aggressive and has significantly better survival in younger patients. For younger patients, advanced nodal involvement is the most important independent prognostic factor, and larynx preservation is comparable to TL in survival rate.

Citing Articles

Investigating the Link between Genetic Variants, STAT4 Protein Concentrations, and Laryngeal Squamous Cell Carcinoma: A Comprehensive Analysis of Clinical Manifestations.

Pileckaite E, Vilkeviciute A, Kriauciuniene L, Liutkevicius V, Liutkeviciene R Int J Mol Sci. 2024; 25(18).

PMID: 39337665 PMC: 11432593. DOI: 10.3390/ijms251810180.


Survival Analysis of Elderly Patients With Laryngeal Cancer After Total Laryngectomy: A Retrospective Cohort Study.

Avdulla C, Mastronikolis N, Tachirai N, Leotsinidis M, Jelastopulu E Cureus. 2024; 16(5):e60792.

PMID: 38903270 PMC: 11189274. DOI: 10.7759/cureus.60792.


Successful use of sclerotherapy in giant supraglottic vascular malformation.

Tsang W, Meghji S, Masterson L, Fish B BMJ Case Rep. 2024; 17(2).

PMID: 38359957 PMC: 10875521. DOI: 10.1136/bcr-2023-256195.


The outcome of early-stage glottic carcinoma patients treated with radiotherapy: Egyptian National Cancer Institute (NCI-Egypt) experience.

Mohamed A, Hassouna A, Mosalum H, Alnagmy A, Ashour M Rep Pract Oncol Radiother. 2023; 28(4):496-505.

PMID: 37795222 PMC: 10547425. DOI: 10.5603/RPOR.a2023.0052.


Supraglottic NUT Carcinoma: A Case Report and Literature Review.

Higashino M, Kinoshita I, Kurisu Y, Kawata R Case Rep Oncol. 2023; 15(3):980-987.

PMID: 36636674 PMC: 9830291. DOI: 10.1159/000526815.


References
1.
Singh B, Alfonso A, Sabin S, Poluri A, Shaha A, Sundaram K . Outcome differences in younger and older patients with laryngeal cancer: a retrospective case-control study. Am J Otolaryngol. 2000; 21(2):92-7. DOI: 10.1016/s0196-0709(00)85004-8. View

2.
Schantz S, Yu G . Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg. 2002; 128(3):268-74. DOI: 10.1001/archotol.128.3.268. View

3.
Kuper H, Boffetta P, Adami H . Tobacco use and cancer causation: association by tumour type. J Intern Med. 2002; 252(3):206-24. DOI: 10.1046/j.1365-2796.2002.01022.x. View

4.
Forastiere A, Goepfert H, Maor M, Pajak T, Weber R, Morrison W . Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003; 349(22):2091-8. DOI: 10.1056/NEJMoa031317. View

5.
Llewellyn C, Linklater K, Bell J, Johnson N, Warnakulasuriya S . An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol. 2004; 40(3):304-13. DOI: 10.1016/j.oraloncology.2003.08.015. View